Rocky Mountain Spotted Fever

• FDA approval · 2024-12-04
  FDA Approved: DOXYCYCLINE — Original Application (Amneal Pharmaceuticals LLC)

  FDA approved Amneal Pharmaceuticals LLC's generic doxycycline as an original ANDA product.

• FDA approval · 2022-12-07
  FDA Approved: DOXYCYCLINE — Original Application (Par Health USA, LLC)

  FDA approved a generic doxycycline product under an original new drug application by Par Health USA, LLC (ANDA216690).

• CLINICAL_TRIALS trial_result · 2022-05-31
  Clinical Trial Update: Efficacy of Azithromycin Plus Doxycycline Versus Doxycycline Plus Placebo in Patients With Rocky Mountain Spotted Fever [Phase 3]

  Phase 3 trial evaluating azithromycin plus doxycycline versus doxycycline plus placebo for Rocky Mountain spotted fever.

• FDA approval · 2015-09-21
  FDA Approved: DOXYCYCLINE HYCLATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved a supplemental application for Doxycycline Hyclate by Hikma Pharmaceuticals USA Inc., indicating a change to the product's labe…

• FDA approval · 2014-03-05
  FDA Approved: DOXYCYCLINE — Original Application (Lupin Pharmaceuticals, Inc.)

  FDA approves Lupin Pharmaceuticals' generic doxycycline (DOXYCYCLINE) under an original application.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.